What is the latest news on THRD?

Quantisnow has not tracked any new filings, ratings or press releases for THRD in the last 30 days. The most recent wire item was published on August 14, 2025.

Where does THRD stock trade?

Third Harmonic Bio Inc. (THRD) is listed on NASDAQ.

What sector and industry is THRD in?

Third Harmonic Bio Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.

When did Third Harmonic Bio Inc. go public?

Third Harmonic Bio Inc. (THRD) completed its IPO in 2022.

What are analysts saying about THRD?

Across the last 6 analyst actions on Third Harmonic Bio Inc., there was 1 upgrade and 3 downgrades. The most recent action was from Stifel: Hold with a $5.00 price target on 2025-03-28. Recent price targets range from $5.00 to $23.00.

What companies are similar to THRD?

Notable peers in the same industry include MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories). Compare THRD side-by-side with any of them on Quantisnow.

How can I track THRD on Quantisnow?

Quantisnow aggregates Third Harmonic Bio Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow THRD to receive live email and push alerts on every new disclosure.

THRD

NASDAQ

Third Harmonic Bio Inc.

SectorHealth Care IndustryBiotechnology: Pharmaceutical PreparationsIPO2022

Follow + get alerts

Third Harmonic Bio Inc. (THRD) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for THRD in the last 30 days. The most recent was published Aug 14, 2025.

Latest news

25 items

457dINSIDER
CEO Holles Natalie C. disposed of 1,218,836 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
457dINSIDER
Director Seidel Hans Martin disposed of 85,753 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
457dINSIDER
SEC Form 4 filed by Director Soloway Thomas P
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
457dINSIDER
Director Iwicki Mark T disposed of 128,631 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
457dINSIDER
SEC Form 4 filed by Chief Financial & Bus. Officer Murphy Christopher M.
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
457dINSIDER
SEC Form 4 filed by Director Gladstone Michael
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
457dINSIDER
Director Bonita David P disposed of 5,779,071 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
460dSEC
SEC Form 15-12G filed by Third Harmonic Bio Inc.
15-12G - Third Harmonic Bio, Inc. (0001923840) (Filer)
470dSEC
SEC Form EFFECT filed by Third Harmonic Bio Inc.
EFFECT - Third Harmonic Bio, Inc. (0001923840) (Filer)
471dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
471dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
471dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
471dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
471dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
471dSEC
SEC Form POS AM filed by Third Harmonic Bio Inc.
POS AM - Third Harmonic Bio, Inc. (0001923840) (Filer)
471dSEC
SEC Form 25 filed by Third Harmonic Bio Inc.
25 - Third Harmonic Bio, Inc. (0001923840) (Filer)
481dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
520dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
520dPR
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third quarter of 2025 THB335 demonstrated 85% serum tryptase reduction with an encouraging safety profile in an additional Phase 1 cohort evaluating 100mg dose with new drug product capsule formulation Company initiating a sale process of THB335 SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (NASDAQ:THRD) today announced that its stockholders overwhelmingly approved the previously proposed Plan of Liquidation and
521dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
548dSEC
SEC Form SCHEDULE 13G filed by Third Harmonic Bio Inc.
SCHEDULE 13G - Third Harmonic Bio, Inc. (0001923840) (Subject)
548dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Third Harmonic Bio Inc.
SCHEDULE 13G/A - Third Harmonic Bio, Inc. (0001923840) (Subject)
551dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Third Harmonic Bio Inc.
SCHEDULE 13G/A - Third Harmonic Bio, Inc. (0001923840) (Subject)
555dSEC
SEC Form 10-Q filed by Third Harmonic Bio Inc.
10-Q - Third Harmonic Bio, Inc. (0001923840) (Filer)
568dSEC
SEC Form DEFA14A filed by Third Harmonic Bio Inc.
DEFA14A - Third Harmonic Bio, Inc. (0001923840) (Filer)

THRD FAQ

7 questions

What is the latest news on THRD?
Quantisnow has not tracked any new filings, ratings or press releases for THRD in the last 30 days. The most recent wire item was published on August 14, 2025.
Where does THRD stock trade?
Third Harmonic Bio Inc. (THRD) is listed on NASDAQ.
What sector and industry is THRD in?
Third Harmonic Bio Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
When did Third Harmonic Bio Inc. go public?
Third Harmonic Bio Inc. (THRD) completed its IPO in 2022.
What are analysts saying about THRD?
Across the last 6 analyst actions on Third Harmonic Bio Inc., there was 1 upgrade and 3 downgrades. The most recent action was from Stifel: Hold with a $5.00 price target on 2025-03-28. Recent price targets range from $5.00 to $23.00.
What companies are similar to THRD?
Notable peers in the same industry include MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories). Compare THRD side-by-side with any of them on Quantisnow.
How can I track THRD on Quantisnow?
Quantisnow aggregates Third Harmonic Bio Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow THRD to receive live email and push alerts on every new disclosure.